Minerva Neurosciences (NERV) Misses Q4 EPS by 2c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
• AutoZone beats profit view but misses on revenue